术前MR预测无微血管侵犯孤立性肝细胞癌早期复发
本研究纳入124例MVI阴性孤立性HCC患者,术前行动态增强1.5-T MR,分析LI-RADS及非LI-RADS影像特征与早期复发的关系,发现肿瘤大小、边缘不光滑及马赛克架构为独立预测因素,并构建列线图,C-index为0.743(95%CI: 0.697-0.788)。
要点
- 肿瘤大小、边缘不光滑、马赛克架构是MVI阴性HCC术后早期复发的独立MR预测因素。
- 基于上述特征构建的列线图具有中等 discriminative ability(C-index 0.743)。
- 术前MR评估这些特征可能有助于识别早期复发高危的MVI阴性HCC患者。
关键影像表现/征象
- 多因素分析显示肿瘤大小(p=0.045)、边缘不光滑(p=0.013)和马赛克架构(p=0.035)与早期复发独立相关。
诊断标准与关键数值
- 列线图预测早期复发的C-index为0.743(95%CI: 0.697-0.788)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to identify preoperative MR imaging features for predicting early recurrence after curative resection of solitary hepatocellular carcinoma (HCC) without microvascular invasion (MVI).
METHODS: 124 patients with MVI-negative HCC who underwent preoperative dynamic contrast-enhanced 1.5-T MR imaging before surgical resection were included. Liver Imaging Reporting and Data System (LI-RADS v2018) imaging features and three non-LI-RADS MR imaging features for predicting early recurrence (intrahepatic recurrence<2 years) were identified by univariable and multivariable analyses. A nomogram was constructed for individualized risk estimation, and its predictive accuracy and discriminative ability were identified by concordance index (C-index) and calibration curve.
RESULTS: In multivariable analysis, tumor size (p = 0.045), nonsmooth tumor margin (p = 0.013), and presence of mosaic architecture (p = 0.035) were independent significant variables associated with early recurrence. These were all incorporated to establish the nomogram. The C-index of the nomogram was 0.743 (95 % CI: 0.697-0.788).
CONCLUSION: At dynamic contrast-enhanced MR imaging, tumor size, nonsmooth tumor margin, and presence of mosaic architecture may be helpful to predict early recurrence of solitary HCC without MVI after curative resection.
引用
- Wei Y, Pei W, Qin Y, et al. Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasion. Eur J Radiol. 2021. PMID: 33773401. doi:10.1016/j.ejrad.2021.109663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。